20 Most Expensive Stocks Insiders Are Dumping In March

Page 12 of 19

8. Thermo Fisher Scientific Inc. (NYSE:TMO)

Market Capitalization: $194.04 billion

Thermo Fisher provides a wide range of life sciences solutions, analytical instruments, diagnostics, laboratory products, and biopharma services globally. Its offerings include products for biological research, drug and vaccine production, clinical diagnostics, and laboratory research across various industries. The Waltham, Massachusetts-headquartered company operates under several brands such as Thermo Scientific, Invitrogen, and Applied Biosystems.

For the full year 2024, Thermo Fisher disclosed revenue of $42.88 billion, flat compared to 2023. Full year GAAP diluted earnings per share (EPS) grew 7% to $16.53.

In recent developments, Thermo Fisher launched the Thermo Scientific Vulcan Automated Lab, a system designed to improve productivity and yield, and reduce costs for semiconductor manufacturers. The solution aims to address the growing demand for advanced metrology data in semiconductor manufacturing as technologies become more complex. Marc N. Casper, CEO of Thermo Fisher, emphasized the company’s expertise in electron microscopy and AI to help semiconductor manufacturers enhance efficiency.

In March, three insiders, including the chairman and CEO, sold around $12.28 million worth of Thermo Fisher shares at an average price of $520.17 per share. The stock currently trades at $514.34 per share, having lost 1.13% year-to-date, and 9.58% over the past 12 months.

Based on 18 Wall Street analysts’ ratings, Thermo Fisher stock is a “Strong Buy” with a price target of $662.00. According to TipRanks, the average price target represents a 28.71% upside from the latest price.

Thermo Fisher is also one of the 12 best diagnostics stocks to invest in right now.

Page 12 of 19